Pharmaceutical administration systems containing a mixture of im
Pharmaceutical composition for treatment of sudden deafness
Pharmaceutical composition of human interferon-α2 and...
Pharmaceutical compositions and their use in the treatment of pa
Pharmaceutical compositions containing interferons and fatty aci
Pharmaceutical formulation for nasal administration
Pharmaceutical products
Polyethylene glycol modified interferon therapy
Polyethylene glycol modified interferon therapy
Polyethylene glycol modified interferon therapy
Polyethylene-protein conjugates
Polyol-IFN-&bgr;conjugates modified at Cys-17 and...
Polypeptide having gamma-interferon activity lacking amino acids
Polypeptides having interferon activity
Polypeptides of the IFNα-21 gene
Polypeptides of the IFNα-21 gene
Polypeptides of the IFNα-7 gene
Potentiator for interferon and an antiviral activity-potentiatin
Preparation for activation of natural killer cells (NK-cells), s
Preparation of polypeptides having human .gamma.-interferon acti